The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries. [electronic resource]
Producer: 20110209Description: 1051-8 p. digitalISSN:- 1876-7605
- Aged
- Angioplasty, Balloon, Coronary -- adverse effects
- Cardiovascular Agents -- administration & dosage
- Chi-Square Distribution
- Coronary Artery Disease -- mortality
- Drug-Eluting Stents
- Female
- Humans
- Kaplan-Meier Estimate
- Male
- Metals
- Middle Aged
- Myocardial Infarction -- etiology
- Netherlands
- Paclitaxel -- administration & dosage
- Proportional Hazards Models
- Prosthesis Design
- Registries
- Risk Assessment
- Risk Factors
- Sirolimus -- administration & dosage
- Stents
- Thrombosis -- etiology
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.